# OnCo record chimigen-bio (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/chimigen-bio/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "chimigen-bio" ;
  schema:name "Chimigen Bio"@en ;
  schema:alternateName "Chimigen Biomedical (Chengdu) Co., Ltd."@en, "凯米生物"@en, "ChimiVac"@en, "Chimivac Inc"@en ;
  schema:description "Chimigen Bio makes off-the-shelf treatment vaccines that deliver pieces of a tumour protein straight to the immune cells that start an immune response. Its prostate cancer vaccine, KMV002, began an early trial in 2026 for advanced prostate cancer that no longer responds to hormone treatment."@en ;
  schema:url <https://onco.cc/companies/chimigen-bio/>, <https://www.chimigen.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.chimigen.com/>, <http://www.chimivac.com/>, <https://www.chimigen.com/science.html>, <https://clinicaltrials.gov/study/NCT07866300> ;
  schema:addressCountry "CN" ;
  onco:cancers <https://onco.cc/cancers/prostate-mcrpc/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/shared-antigen-vaccine/> ;
  onco:targets <https://onco.cc/targets/pap/> .